Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 31, 2020

SELL
$334.87 - $493.06 $227,041 - $334,294
-678 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$320.01 - $409.07 $216,966 - $277,349
678 New
678 $238,000
Q1 2019

May 09, 2019

SELL
$224.3 - $317.41 $2.38 Million - $3.37 Million
-10,603 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$220.1 - $309.0 $4.84 Million - $6.8 Million
-21,999 Reduced 67.48%
10,603 $2.46 Million
Q3 2018

Nov 01, 2018

SELL
$289.28 - $326.15 $4.76 Million - $5.37 Million
-16,451 Reduced 33.54%
32,602 $10.2 Million
Q2 2018

Aug 07, 2018

SELL
$244.1 - $303.88 $5.46 Million - $6.8 Million
-22,370 Reduced 31.32%
49,053 $14.2 Million
Q1 2018

Apr 30, 2018

BUY
$233.97 - $274.11 $16.7 Million - $19.6 Million
71,423 New
71,423 $17.9 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.68B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.